Cyclo G6

Efficacy - Confidence in IOP Control

Long-term results from National University Hospital (NUHS), Singapore prospective clinical study¹ showed:

• 33% IOP reduction at 18 months, N = 38 patients
• 61% med reduction (2.1 to 1.3)
• 73% success rate with 1.3 sessions

Excellent Safety Profile

The MicroPulse^® P3 Glaucoma Device powered by the CYCLO G6™ Glaucoma Laser System enables a versatile procedure with multiple safety benefits:

• Non-Incisional
• Minimal to no inflammation post-op
• Patient downtime is significantly low
• Repeatable
• Predictable

2014 Randomized study shows MicroPulse P3 has similar IOP reduction as G-Probe with higher success rate and no hypotony